🚀 VC round data is live in beta, check it out!
Prolight Diagnostics Valuation Multiples
Discover revenue and EBITDA valuation multiples for Prolight Diagnostics and similar public comparables like Jin Medical International, Nortech Systems, Farmaceutica Remedia, iZafe Group and more.
Prolight Diagnostics Overview
About Prolight Diagnostics
Prolight Diagnostics AB along with its subsidiaries, develops Point-of-Care (POC) systems, which are small, portable instruments and disposable cartridges for performing in-vitro diagnostic (IVD) tests from a drop of blood. Its product portfolio includes Psyros, a digital POC technology, and Microflex.
Founded
1999
HQ
Employees
21
Website
Sectors
Financials (FY)
EV
$17M
Prolight Diagnostics Financials
Prolight Diagnostics reported last fiscal year revenue of — and negative EBITDA of ($5M).
In the same fiscal year, Prolight Diagnostics generated $2M in gross profit, ($5M) in EBITDA losses, and had net loss of ($5M).
Prolight Diagnostics P&L
In the most recent fiscal year, Prolight Diagnostics reported revenue of — and EBITDA of ($5M).
Prolight Diagnostics expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Gross Profit | — | XXX | $2M | XXX | XXX | XXX |
| EBITDA | — | XXX | ($5M) | XXX | XXX | XXX |
| Net Profit | — | XXX | ($5M) | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Prolight Diagnostics Stock Performance
Prolight Diagnostics has current market cap of $23M, and enterprise value of $17M.
Market Cap Evolution
Prolight Diagnostics' stock price is $1.91.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $17M | $23M | -0.5% | XXX | XXX | XXX | $-0.44 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialProlight Diagnostics Valuation Multiples
Prolight Diagnostics trades at (3.1x) EV/EBITDA.
Prolight Diagnostics Financial Valuation Multiples
As of March 28, 2026, Prolight Diagnostics has market cap of $23M and EV of $17M.
Equity research analysts estimate Prolight Diagnostics' 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Prolight Diagnostics has a P/E ratio of (4.3x).
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $23M | XXX | $23M | XXX | XXX | XXX |
| EV (current) | $17M | XXX | $17M | XXX | XXX | XXX |
| EV/EBITDA | — | XXX | (3.1x) | XXX | XXX | XXX |
| EV/EBIT | — | XXX | (4.4x) | XXX | XXX | XXX |
| EV/Gross Profit | — | XXX | 10.1x | XXX | XXX | XXX |
| P/E | — | XXX | (4.3x) | XXX | XXX | XXX |
| EV/FCF | — | XXX | (2.7x) | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Prolight Diagnostics Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
Prolight Diagnostics Margins & Growth Rates
Prolight Diagnostics' revenue in the last fiscal year grew by —.
Prolight Diagnostics Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| EBITDA Growth | — | XXX | 102% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Prolight Diagnostics Public Comps
See public comps and valuation multiples for other Medical Supplies comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Jin Medical International | XXX | XXX | XXX | XXX | XXX | XXX |
| Nortech Systems | XXX | XXX | XXX | XXX | XXX | XXX |
| Farmaceutica Remedia | XXX | XXX | XXX | XXX | XXX | XXX |
| iZafe Group | XXX | XXX | XXX | XXX | XXX | XXX |
| Balsm Alofoq | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Prolight Diagnostics M&A Activity
Prolight Diagnostics acquired XXX companies to date.
Last acquisition by Prolight Diagnostics was on XXXXXXXX, XXXXX. Prolight Diagnostics acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Prolight Diagnostics
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialProlight Diagnostics Investment Activity
Prolight Diagnostics invested in XXX companies to date.
Prolight Diagnostics made its latest investment on XXXXXXXX, XXXXX. Prolight Diagnostics invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Prolight Diagnostics
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Prolight Diagnostics
| When was Prolight Diagnostics founded? | Prolight Diagnostics was founded in 1999. |
| Where is Prolight Diagnostics headquartered? | Prolight Diagnostics is headquartered in Sweden. |
| How many employees does Prolight Diagnostics have? | As of today, Prolight Diagnostics has over 21 employees. |
| Is Prolight Diagnostics publicly listed? | Yes, Prolight Diagnostics is a public company listed on Nasdaq Global Market. |
| What is the stock symbol of Prolight Diagnostics? | Prolight Diagnostics trades under PRLD ticker. |
| When did Prolight Diagnostics go public? | Prolight Diagnostics went public in 2017. |
| Who are competitors of Prolight Diagnostics? | Prolight Diagnostics main competitors are Jin Medical International, Nortech Systems, Farmaceutica Remedia, iZafe Group. |
| What is the current market cap of Prolight Diagnostics? | Prolight Diagnostics' current market cap is $23M. |
| Is Prolight Diagnostics profitable? | No, Prolight Diagnostics is not profitable. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.